Bayer Recalls Afrin Original Nasal Spray Due to Child Poisoning Risk
Bayer is recalling about 786,100 units of Travel Size Afrin Original Nasal Spray 6 mL bottles because they lack child-resistant packaging, posing a risk of serious injury or illness to children.
What this CPSC product recall tells you, and what most readers miss
This notice was issued by CPSC on May 6, 2026 and geographically references United States. Its severity classification of "high" signals how the issuing agency weighs the risk of harm if no action is taken — "critical" and "high" tier alerts typically carry direct consumer actions, while "medium" and "low" tend toward informational guidance or monitoring advisories. The category it belongs to — Product Recalls — determines the regulatory framework behind it, which shapes what remedies (refunds, replacements, recalls, evacuations) are available to affected individuals and who holds statutory responsibility for enforcement.
Most readers skim a notice like this, check whether they are personally affected, and move on. The more useful lens is to read it as a data point about the issuing system: how quickly CPSC detected the hazard, how precise the geographic or product-identifier scope is, and whether similar notices have clustered in the same category or region in the last 90 days. Cluster patterns frequently precede a broader regulatory action — a single localized CPSC product recall is isolated; three of them within a quarter often indicate a supply-chain, infrastructure, or seasonal driver that will keep producing notices until something structural changes.
For decision-making, Areazine pairs each alert with the original agency URL, the full agency name, and a timestamp so you can verify the notice against the primary source before acting on it. Tags on this item (recall, product-safety, cpsc, nasal spray) map to related alerts in the same area of risk — browsing them together gives a clearer picture than any single notice alone, because the shape of an ongoing issue only becomes visible across multiple sequential alerts.
What Happened
This recall involves unexpired Travel Size Afrin® Original Nasal Spray 6 mL bottles with specific lot numbers, as they are not in child-resistant packaging and do not meet the required labeling standards under the Poison Prevention Packaging Act, posing a risk of serious injury or illness from child poisoning.
Which Products Are Affected
The affected products are Travel Size Afrin® Original Nasal Spray 6 mL bottles with lot numbers 230361, 240822, 241198, 250066, 250152, 250646, and 250831. About 786,100 units were sold at retailers such as convenience stores and travel hubs including airports from September 2024 to April 2026 for about $7 to $9. No other sizes of Afrin are included in this recall.
What You Should Do
Consumers should immediately secure the recalled bottles out of sight and reach of children and visit the webform at www.livewell.bayer.com/afrin-original-spray-recall to request a refund. They will need to take and submit a photo of the product before disposing of it.
Why This Matters
This recall underscores the importance of child-resistant packaging for products containing certain active ingredients to prevent accidental poisoning in young children. It affects a large number of units sold nationwide, highlighting potential safety risks in everyday consumer products.
Source
This information is from the U.S. Consumer Product Safety Commission (CPSC). For more details, visit: https://www.cpsc.gov/Recalls/2026/Bayer-Recalls-6-mL-Size-Afrin-Original-Nasal-Spray-Bottles-Due-to-Risk-of-Serious-Injury-or-Illness-from-Child-Poisoning-Violates-Mandatory-Standard-for-Child-Resistant-Packaging
Original source: CPSC Official Notice ↗
Related Product Recalls
All Product Recalls →Frequently Asked Questions
Common questions about this CPSC product recall.